The ability to achieve precision healthcare — care that is personalized, patient-centered, and accessible — will depend on new ways of generating evidence that informs treatment decisions in the clinic, regulatory decisions by the U.S. Food and Drug Administration and its international counterparts, and coverage and payment decisions by Medicare and other payers.
Read MoreWord from the Editors
The ongoing consolidation across provider organizations, cost pressures, and labor shortages are shaping the post-COVID healthcare landscape. Required hospital and health plan price transparency will bring increased scrutiny to the private market, while the Centers for Medicare and Medicaid Services must make key decisions about telemedicine. Against this backdrop, HMPI explores salient issues around health plan designs and service payment models, drug development, and the related policy implications. Read More
Regi’s “Innovating in Health Care” Cases
“Regi”, aka Regina E. Herzlinger, is the Nancy McPherson Professor of Business Administration at Harvard Business School and author of bestselling trade books on healthcare. “Regi’s ‘Innovating in Health Care’ Cases”, a regular HMPI feature, highlights teaching materials that focus on innovating across healthcare. Our case in this issue explores The Himalayan Cataract Project, an illustration of a time-driven activity-based cost study. Read more
Also In this Issue
Shopping for Healthcare: Can We Be Good Consumers?
The author explores the successes of market transparency and healthcare consumerism, certain market-based efforts, and the underemphasized value of agency as a guidepost for healthcare reform.
Read moreWorkforce Woes: Tackling Labor and Productivity Challenges in Healthcare
Other industries offer lessons on how healthcare organizations can optimize team sizes, better allocate skill sets, and create flexible labor models.
Read moreCommercializing Science: Turning Life Science Discoveries Into Lifesaving Products – Part 1: Overcoming Barriers to Commercialization of Original Research
Multiple challenges stand in the way of translating academic research into products that benefit patients.
Read moreCommercializing Science: Turning Life Science Discoveries Into Lifesaving Products – Part 2: What Makes Life Sciences Innovation Ecosystems Tick
The Bay Area and Greater Boston are the world’s preeminent biotechnology hubs. What lies behind their success?
Read moreAuction Pricing for Medicare Services: Could It Be Applied to Cataract Surgery?
This novel approach could transform the pricing of healthcare services for public payers in the United States – decreasing prices while maintaining the quality of cataract surgery.
Read moreThe Business of Health Care: Technology and Access
An annual conference hosted by the University of Miami addressed the impact of technology and access on patients and providers, workforce shortages, value-based care, and the substance abuse epidemic.
Read more